)
Edge26 Jun 2026
The Universal Language: Inventing the Barcode
How lines in the sand on a Miami beach became the most scanned symbol in human history, and why it took decades for anyone to care.
4DMedical
4DMedical (4DX) investor relations material
4DMedical Life Sciences Virtual Investor Forum summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Life Sciences Virtual Investor Forum summary24 Jun, 2026
Company overview and recent developments
Specializes in cardiothoracic imaging with operations across three continents and recent expansion into Europe.
Holds nine FDA approvals and is listed on the S&P/ASX 200 index.
Recent acquisition in Europe strengthens presence and supports SaaS revenue growth.
Product innovation and market impact
CT:VQ, the third-generation flagship product, enables functional lung imaging using existing CT infrastructure, eliminating the need for new hardware.
Replaces traditional nuclear VQ scans, providing 3D, high-resolution images without radioactive agents or contrast injections.
Offers significant workflow improvements, faster diagnosis, and better patient experience.
Economic and clinical advantages
Delivers higher reimbursement and economic upside for hospitals and radiology providers, with up to AUD 1,500 per commercial scan.
Clinical studies show improved surgical outcomes, with LVRS success rates rising from 46% to 76%.
Rapid adoption by leading U.S. hospitals and imaging chains, including Stanford, Mayo, Cleveland Clinic, and SimonMed.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from 4DMedical
- CLEAR study, SimonMed deal, and European acquisition drive global lung health expansion.4DX
Investor update9 Jun 2026 - CT:VQ™ adoption accelerates globally, driving SaaS growth and robust financial performance.4DXQ3 2026 TU7 Jun 2026
- CT:VQ drives improved lung therapy outcomes, workflow efficiency, and rapid clinical adoption.4DXStatus update21 May 2026
- CT-based imaging is set to replace nuclear VQ scans, driving rapid growth and market expansion.4DXAI & Technology Virtual Investor Conference23 Apr 2026
- FDA clearance, Philips deal, and SaaS growth drive revenue up 56%, but losses persist.4DXH2 202525 Mar 2026
- Revenue up 422%, Imbio acquired, Philips US deal signed, but $36m net loss recorded.4DXH2 202425 Mar 2026
- FDA clearance, SaaS growth, and $150M raise drive global expansion amid audit qualification.4DXH1 202615 Mar 2026
- Revenue up 265% to $2.9m, FDA wins and U.S. deals drive expansion despite higher losses.4DXH1 202526 Dec 2025
- Rapid growth and new CT-based products set the stage for major disruption in lung diagnostics.4DXInvestor Update16 Dec 2025
Next 4DMedical earnings date
H2 202627 Aug, 2026
4DMedical
Next 4DMedical earnings date
H2 202627 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage